<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="publisher-id">MEDI</journal-id>
      <journal-title-group>
        <journal-title>Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0025-7974</issn>
      <issn pub-type="epub">1536-5964</issn>
      <publisher>
        <publisher-name>Wolters Kluwer Health</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27741150</article-id>
      <article-id pub-id-type="pmc">5072977</article-id>
      <article-id pub-id-type="doi">10.1097/MD.0000000000005169</article-id>
      <article-id pub-id-type="art-access-id">05169</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>4500</subject>
        </subj-group>
        <subj-group>
          <subject>Research Article</subject>
          <subject>Clinical Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Eosinophilic esophagitis in an octogenarian</article-title>
        <subtitle>A case report and review of the literature</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Trifan</surname>
            <given-names>Anca</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stoica</surname>
            <given-names>Oana</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chihaia</surname>
            <given-names>Catalin-Alexandru</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Danciu</surname>
            <given-names>Mihai</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stanciu</surname>
            <given-names>Carol</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
          <xref>
            <sup>&#x2217;</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Singeap</surname>
            <given-names>Ana-Maria</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Lupu.</surname>
            <given-names>Vasile Valeriu</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>&#x201C;Gr T Popa&#x201D; University of Medicine and Pharmacy</aff>
      <aff id="aff2"><label>b</label>&#x201C;St. Spiridon&#x201D; Emergency Hospital, Institute of Gastroenterology and Hepatology, Iasi, Romania.</aff>
      <author-notes id="cor1">
        <corresp><label>&#x2217;</label>Correspondence: Carol Stanciu, &#x201C;St. Spiridon&#x201D; Emergency Hospital, Institute of Gastroenterology and Hepatology, 1 Independentei, Iasi, Romania (e-mail: <email>stanciucarol@yahoo.com</email>)</corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>10</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>14</day>
        <month>10</month>
        <year>2016</year>
      </pub-date>
      <volume>95</volume>
      <issue>41</issue>
      <elocation-id>e5169</elocation-id>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>7</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>8</day>
          <month>9</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>9</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0">
          <license-p>This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="medi-95-e5169.pdf"/>
      <abstract>
        <title>Abstract</title>
        <sec sec-type="intro">
          <title>Introduction:</title>
          <p>Eosinophilic esophagitis (EoE) is a chronic, immune/antigen-mediated disease characterized clinically by symptoms related to esophageal dysfunction and histologically by a marked eosinophilic infiltrate in the esophageal mucosa. What was once considered a rare disease has nowadays become one of the most frequent esophageal diseases in the Western countries, occupying a place just next to the gastroesophageal reflux disease. EoE etiology and pathogenesis remain largely unknown, although most studies consider that allergic and genetic factors play the most important role.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods:</title>
          <p>We report the case of EoE in an elderly male (octogenarian), giving a brief review of the current data related to epidemiology, pathogenesis, diagnosis, and treatment of the disease.</p>
        </sec>
        <sec sec-type="results">
          <title>Results:</title>
          <p>Dysphagia to solid foods was the leading symptom, and endoscopic findings included white exudates, longitudinal furrows, and concentric mucosal rings, all suggestive for EoE. Diagnosis relied on histological findings in esophageal mucosal biopsies (&gt;30 eosinophils per high power field).</p>
          <p>He was treated with topical steroids for 8 weeks, symptoms improved gradually and the patient remained in remission at the 8-month follow-up.</p>
        </sec>
        <sec sec-type="conclusion">
          <title>Conclusion:</title>
          <p>This case emphasizes that EoE may occur in very old patients and gastroenterologists should have a high index of suspicion of this disorder in any elderly with dysphagia and endoscopic relevant features.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>corticosteroids</kwd>
        <kwd>dietary therapy</kwd>
        <kwd>dysphagia</kwd>
        <kwd>eosinophilic esophagitis</kwd>
        <kwd>food allergy</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <label>1</label>
      <title>Introduction</title>
      <p>Eosinophilic esophagitis (EoE) was defined by an international expert panel as a chronic, immune/antigen-mediated, esophageal disease characterized clinically by symptoms related to esophageal dysfunction and histologically by a marked esophageal eosinophilic inflammation.<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> Although there were a few case reports of esophageal eosinophilia associated with achalasia or eosinophilic gastroenteritis, published in late 1970s and early 1980s,<sup>[<xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref>]</sup> EoE was described only a decade later as a distinct clinicopathological disease.<sup>[<xref rid="R4" ref-type="bibr">4</xref>]</sup> In recent years, EoE has become an increasingly recognized disease discussed at all major international gastroenterology meetings, with an exponential increase in the number of related publications (nearly 1200 PubMed). In addition to a genuine increase, the dramatic growth in the incidence of EoE registered over the last decade throughout the Western world (Europe and North America) is without a doubt influenced by an increased clinical awareness and a large number of esophageal biopsies carried out during endoscopic examinations.<sup>[<xref rid="R5" ref-type="bibr">5</xref>]</sup> EoE is uncommon in elderly patients (aged &gt;65 years), and upon a thorough research, we were able to find only very few case reports in octogenarians in the published literature.<sup>[<xref rid="R6" ref-type="bibr">6</xref>]</sup> EoE is a progressive disease, with a significant impact on the quality of life. Unrecognized and untreated, it may lead to irreversible structural lesions of the esophagus. We hereby present a case of EoE in an elderly male, briefly reviewing the current data on EoE epidemiology, pathogenesis, diagnosis, and treatment.</p>
    </sec>
    <sec>
      <label>2</label>
      <title>Case report</title>
      <p>An 89-year-old Caucasian man was referred to our institution in October 2015 with a 1-year history of dysphagia for solid-food, chest pain, and (often) sensation of food impaction which resolved after ingestion of fluids. He did not have pyrosis or acid regurgitation, nor did he have a significant medical history (without any particular history of allergic disease). His symptoms worsened over the past 6 months, but his weight remained stable during this time. Physical examination was unremarkable, electrocardiogram was normal, hematological and biochemical parameters were within normal limits. For his symptoms, he had undergone an upper endoscopy examination performed at another hospital, but he was unable to produce any documentation of this investigation. He remembers, however, only that &#x201C;the doctor assured him that everything was ok&#x201D; and prescribed pantoprazole 40&#x200A;mg/d which he has followed for 3 months with no results to relieve his symptoms.</p>
      <p>The upper endoscopy examination was repeated at our institution, showing white exudates, longitudinal furrows, and concentric rings, all suggestive for EoE (Figs. <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>). Biopsy specimens were obtained from proximal and distal esophagus; histologic examination revealed marked infiltration of more than 30 eosinophilis/high power field [HPF] (Fig. <xref ref-type="fig" rid="F3">3</xref>), confirming the diagnosis of EoE.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Endoscopic view of the esophagus: prominent fixed esophageal rings (trachea-like aspect).</p>
        </caption>
        <graphic xlink:href="medi-95-e5169-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Endoscopic view showing longitudinal linear furrow (white arrows) and white exudates (black arrows).</p>
        </caption>
        <graphic xlink:href="medi-95-e5169-g002"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Proximal esophageal biopsy: high power field (HPF) showing a heavy eosinophilic infiltration, &gt;30 eosinophils/HPF (HE, &#xD7;400 magnification), and a microabscess formation (clustering of more than 5 eosinophilis) (white arrow).</p>
        </caption>
        <graphic xlink:href="medi-95-e5169-g003"/>
      </fig>
      <p>Based on clinical symptomatology (and lack of response to the 3-month proton pump inhibitors [PPI] therapy), as well as endoscopic and histologic findings, the patient was diagnosed with EoE. He was treated with fluticasone 250&#x200A;&#x3BC;g multiple-dose inhaler, 4 puffs swallowed twice a day for 8 weeks. Symptoms improved gradually, and an upper endoscopy performed after 3 months showed marked improvement in endoscopic appearance. The patient remained in remission at the 8-month follow-up.</p>
    </sec>
    <sec>
      <label>3</label>
      <title>Discussion</title>
      <p>Although EoE was first described in adults, it has been known best as a children's disease until recently, when several studies and a meta-analysis showed that it is more common in adults.<sup>[<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R7" ref-type="bibr">7</xref>&#x2013;<xref rid="R9" ref-type="bibr">9</xref>]</sup> EoE has been reported at any age, predominantly in the male sex, with a male/female ratio of 3:1.<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup> Most frequently, diagnosis is established in the 2nd through 5th decade of life, while cases occurring in very old subjects (octogenarians) have rarely been included in some studies.<sup>[<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R12" ref-type="bibr">12</xref>]</sup> In our patient, the diagnosis was suggested by clinical symptomatology (dysphagia unresponsive to high-dose PPI therapy) and endoscopic findings (rings, furrows, and white exudates), subsequently confirmed by fulfilling histologic criteria (&gt;15 eosinophils/HPF, bazal&#x2014;zone hyperplasia, aggregates of eosinophils).<sup>[<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R13" ref-type="bibr">13</xref>]</sup> In addition to his advanced age, another characteristic was his lack of personal or family history of allergic diseases such as asthma, atopic dermatitis, rhinitis, and food allergies which are present in up to 80% of patients with EoE.<sup>[<xref rid="R14" ref-type="bibr">14</xref>]</sup> The patient was treated successfully with topical corticosteroids. In the following, we will summarize the current data on EoE epidemiology, pathogenesis, diagnosis, and treatment.</p>
      <sec>
        <label>3.1</label>
        <title>Epidemiology, pathogenesis</title>
        <p>Over the past decade, there has been a dramatic increase in both incidence and prevalence of EoE reported in Europe, North America, Asia (including Japan), and Australia in children as well as adults. Thus, initially known as a rare disease, EoE has nowadays become one of the most frequent esophageal disorders placed next to gastroesophageal reflux disease (GERD). A recent meta-analysis reported pooled incidence and prevalence rates of 3.7/100,000 persons/year and 22.7 cases/100,000 inhabitants, respectively.<sup>[<xref rid="R9" ref-type="bibr">9</xref>]</sup> Using the new international classification of diseases, 9th revision code (ICD-9), Dellon et al<sup>[<xref rid="R15" ref-type="bibr">15</xref>]</sup> found the USA prevalence estimate for EoE of 56.7/100,000 persons. In Canada, 1 study reported a 5-fold increase in the incidence of EoE,<sup>[<xref rid="R5" ref-type="bibr">5</xref>]</sup> while a 19.5-fold rise in the incidence of EoE from 1992 to 2012 was reported in Denmark.<sup>[<xref rid="R16" ref-type="bibr">16</xref>]</sup> Van Rhijn et al<sup>[<xref rid="R8" ref-type="bibr">8</xref>]</sup> estimated the incidence rates of EoE from 1996 to 2010 using a large database in The Netherlands and found a significant increase over the years, being 0.01 in 1996, 0.14 in 2005, and 1.31 per 100,000 persons in 2010, with the highest incidence in 20- to 29-year-old males, and the lowest in the decade 80 to 89 years. This overwhelming growth in the incidence of EoE is most likely influenced by higher clinical awareness and increased number of esophageal biopsies taken during endoscopic examinations<sup>[<xref rid="R5" ref-type="bibr">5</xref>]</sup> rather than being the result of only a genuine increase. Interestingly, the overall incidence and prevalence were higher in adults than in children.<sup>[<xref rid="R7" ref-type="bibr">7</xref>&#x2013;<xref rid="R9" ref-type="bibr">9</xref>]</sup> Thus, considered for several decades as a pediatric disease, EoE has mostly become an adult disease. The etiology of EoE remains largely unknown, although most studies mention that allergic and genetic factors play the most important role.<sup>[<xref rid="R17" ref-type="bibr">17</xref>]</sup> Recent studies consider EoE to be a genetic disease. Thus, EoE genome-wide association studies identified 5 susceptibility loci, among which 2 are specific to EoE.<sup>[<xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R19" ref-type="bibr">19</xref>]</sup> Pathogenesis also remains largely unknown. EoE is considered an allergic disease, activated by food allergens and aeroallergens, the allergic mechanism involving both Immunoglobulin E (IgE)-mediated (immediate type) and non-IgE-mediated (delayed type) processes.<sup>[<xref rid="R20" ref-type="bibr">20</xref>]</sup> In the non-IgE-mediated reaction, allergen uptake in the esophagus activates a T helper 2 cell (Th2)-associated immunologic pathway with increased levels of Th2 cytokines interleukin (IL-5) and IL-13, the <italic>eotaxin-3</italic> gene serving as an eosinophilic chemoattractant causing eosinophilic infiltration and inflammation.<sup>[<xref rid="R21" ref-type="bibr">21</xref>]</sup> In the IgE-mediated reaction, mast cells play the important role in the inflammatory process.<sup>[<xref rid="R20" ref-type="bibr">20</xref>]</sup></p>
      </sec>
      <sec>
        <label>3.2</label>
        <title>Diagnosis</title>
        <p>The following diagnostic criteria for EoE have been proposed by updated consensus recommendations <sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> and recent guidelines<sup>[<xref rid="R13" ref-type="bibr">13</xref>]</sup>: the presence of symptoms related to esophageal dysfunction (dysphagia, food bolus impaction and thoracic pain in adults, and unspecific symptoms in children such as feeding dysfunction, abdominal pain, or vomiting); the presence of minimum 15 eosinophils per HPF/400&#xD7; magnification in at least 1 esophageal biopsy<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup>; the persistence of symptoms and/or mucosal esophageal eosinophilia after a 2-month PPI trial<sup>[<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R22" ref-type="bibr">22</xref>]</sup>; and secondary causes of esophageal eosinophilia (GERD, eosinophilic gastroenteritis, hypereosinophilic syndrome, Crohn disease, celiac disease, parasitic infection, collagen vascular diseases, and drugs) have been excluded. A distinctive feature of esophageal eosinophilia is that it is not unitary: more than 3 biopsies should be taken from the upper, middle, and lower parts of esophagus.<sup>[<xref rid="R23" ref-type="bibr">23</xref>]</sup></p>
        <p>The most important differential diagnosis of EoE is GERD. The clinical history (pyrosis and acid regurgitation), response to PPI, and histology (&lt;10 eosinophils/HPF limited to the distal esophagus) suggest GERD. In contrast to GERD, it was initially assumed that patients with EoE do not response to PPI therapy, and therefore a 2-month PPI trial with a double dose was recommended to distinguish patients with EoE from those with GERD. However, the use of this &#x201C;diagnostic PPI-trial&#x201D; has shown that a subset of patients with EoE (approximately 30%) respond both clinically and histologically to treatment with PPI,<sup>[<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R25" ref-type="bibr">25</xref>]</sup> and the term &#x201C;proton pump inhibitor-responsive esophageal eosinophilia&#x201D; (PPI-REE) has been proposed and included in recent guidelines.<sup>[<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R13" ref-type="bibr">13</xref>]</sup> Nowadays, PPI-REE is considered a subphenotype of EoE that respond to PPI therapy.<sup>[<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R26" ref-type="bibr">26</xref>]</sup></p>
        <p>Endoscopic findings in EoE are multiple, non-specific, and include concentric fixed mucosal rings (&#x201C;trachea-like aspect&#x201D;), longitudinal linear furrows, white exudates, fragile, or &#x201C;<italic>cr&#xEA;pe-paper</italic>&#x201D; esophageal mucosa appearance, decreased mucosal vascularity or edema, narrowing, and strictures.<sup>[<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R27" ref-type="bibr">27</xref>]</sup> There had been a lack of agreement between endoscopists in reporting diagnostic endoscopic features of EoE, until Hirano et al<sup>[<xref rid="R28" ref-type="bibr">28</xref>]</sup> proposed the EoE Endoscopic Reference Score (EREFS) as a method of standardizing description and reporting endoscopic features of EoE, validated recently by Dellon et al<sup>[<xref rid="R29" ref-type="bibr">29</xref>]</sup> as a valuable tool for the diagnosis of EoE. It should be underlined that none of the abovementioned endoscopic features of EoE are part of its diagnosis criteria.<sup>[<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R13" ref-type="bibr">13</xref>]</sup> Moreover, endoscopically normal esophagus is found in up to 30% of patients with EoE.<sup>[<xref rid="R22" ref-type="bibr">22</xref>]</sup></p>
      </sec>
      <sec>
        <label>3.3</label>
        <title>Treatment</title>
        <sec>
          <label>3.3.1</label>
          <title>Medical therapy</title>
          <p>Presently, there are no US Food and Drug Administration and European Medical Agency&#x2013;approved medical therapy.</p>
          <p><italic>Corticosteroids:</italic> Swallowed topical corticosteroids (fluticasone, budesonide, and ciclosenide) are effective for inducing clinical, endoscopic, and histologic remission<sup>[<xref rid="R30" ref-type="bibr">30</xref>]</sup> and are currently considered as first-line medical therapy for adults with EoE.<sup>[<xref rid="R13" ref-type="bibr">13</xref>]</sup> The use of topical fluticasone (220&#x2013;880&#x200A;&#x3BC;g twice daily) or budesonide (1&#x2013;2&#x200A;mg once a day or twice a day) for 4 to 6 weeks in randomized, controlled studies resulted in significant improvement in both clinical symptomatology and histology.<sup>[<xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R31" ref-type="bibr">31</xref>]</sup> Clinical and histologic remission is followed by maintenance therapy (the duration and optimal dose of which are not yet established). Patients should avoid eating and drinking for at least half an hour after administration of topical corticosteroids. However, almost all patients relapse after cessation of topical steroids. The main side effect of swallowed topical corticosteroids is the infection of the esophagus or oropharyngeal cavity with <italic>Candida albicans,</italic> occurring in 10% to 15% of patients.<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup></p>
          <p><italic>Leukotriene inhibitors and immunosuppressants</italic> (purine-analogs) did not prove to have any beneficial effects.<sup>[<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R32" ref-type="bibr">32</xref>,<xref rid="R33" ref-type="bibr">33</xref>]</sup></p>
          <p><italic>Biological agents</italic>: A trial performed with anti-IL-5 monoclonal antibody showed a significant reduction of eosinophils in the esophageal tissue and may play an important role in the future therapy of EoE.<sup>[<xref rid="R34" ref-type="bibr">34</xref>]</sup></p>
        </sec>
        <sec>
          <label>3.3.2</label>
          <title>Elimination and elemental diet therapy</title>
          <p>Dietary treatment includes elemental diets, consisting of amino acids&#x2013;based formulas, which eliminate all potential triggers, and elimination diets, which can be either empirical elimination diets based on avoidance of most common triggers (i.e., milk, egg, soy, wheat, peanuts/tree nuts, and fish/shellfish) or test-directed (targeted) elimination diets, based on allergy test results.</p>
          <p>Elemental diets are used to induce rapid disease remission (amino acids formula is not for permanent use).<sup>[<xref rid="R35" ref-type="bibr">35</xref>,<xref rid="R36" ref-type="bibr">36</xref>]</sup> The major drawbacks of elemental diets are the very poor taste (children frequently need nasogastric feeding for delivery of amino acids formula).</p>
          <p>Empirical elimination diets: the most frequently used is the empiric six food elimination diet (SFED): cow's milk, wheat, egg, soy, peanut/tree nuts, and fish/shellfish are eliminated<sup>[<xref rid="R37" ref-type="bibr">37</xref>,<xref rid="R38" ref-type="bibr">38</xref>]</sup> with the advantage that it does not require allergy testing and it allows the consumption of multiple table foods.</p>
          <p>Test-directed elimination diets use allergy tests to identify EoE triggers. However, in practice, allergy tests are of very limited value and, therefore, their usefulness remains questionable.<sup>[<xref rid="R39" ref-type="bibr">39</xref>]</sup></p>
        </sec>
        <sec>
          <label>3.3.3</label>
          <title>Esophageal dilation</title>
          <p>Esophageal dilation is indicated in the presence of irreversible fibrostenotic stricture. Many physicians are fearful to dilate the strictures in EoE patients because of early reports<sup>[<xref rid="R40" ref-type="bibr">40</xref>,<xref rid="R41" ref-type="bibr">41</xref>]</sup> of severe complications (perforations and mucosal tears). However, recent studies (after 2010) have reported good results and very low rate of complications.<sup>[<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R42" ref-type="bibr">42</xref>]</sup></p>
        </sec>
      </sec>
    </sec>
    <sec>
      <label>4</label>
      <title>Conclusion</title>
      <p>Our case report emphasizes that EoE may occur in very old patients, and gastroenterologists should have a high index of suspicion for this esophageal disorder in any elderly adult with clinical symptoms such as dysphagia and food impaction that does not respond to high-dose PPI therapy and in the presence of endoscopic relevant features (furrows, rings, and white exudates). Biopsies should be taken at least from proximal and distal parts of the esophagus to confirm diagnosis.</p>
    </sec>
    <sec>
      <title>Acknowledgments</title>
      <p>We thank the patient who agreed to the publication of this case report. A copy of the written consent (in Romanian language) is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="abbr">
        <p>Abbreviations: EoE = eosinophilic esophagitis, EREFS = EoE Endoscopic Reference Score, GERD = gastroesophageal reflux disease, HPF = high power field, PPI= proton pump inhibitors, PPI-REE = proton pump inhibitor-responsive esophageal eosinophilia.</p>
      </fn>
      <fn fn-type="con">
        <p>Authors&#x2019; contribution: AT and CS made a substantial contribution to the study concept and design and were responsible for critical revision and final approval. AT and A-MS drafted the manuscript. OS and C-AC were responsible for data acquisition and analysis. MD performed histological assessment. All authors read and approved the final version of the manuscript.</p>
      </fn>
      <fn fn-type="COI-statement">
        <p>The authors have no conflicts of interest to disclose.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liacouras</surname><given-names>CA</given-names></name><name><surname>Furuta</surname><given-names>GT</given-names></name><name><surname>Hirano</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Eosinophilic esophagitis: updated consensus recommendations for children and adults</article-title>. <source><italic>J Allergy Clin Immunol</italic></source>
<year>2011</year>; <volume>128</volume>:<fpage>3</fpage>&#x2013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">21477849</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landres</surname><given-names>RT</given-names></name><name><surname>Kuster</surname><given-names>GG</given-names></name><name><surname>Strum</surname><given-names>WB</given-names></name></person-group>
<article-title>Eosinophilic esophagitis in a patient with vigorous achalasia</article-title>. <source><italic>Gastroenterology</italic></source>
<year>1978</year>; <volume>74</volume>:<fpage>1298</fpage>&#x2013;<lpage>1301</lpage>.<pub-id pub-id-type="pmid">648822</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picus</surname><given-names>D</given-names></name><name><surname>Frank</surname><given-names>PH</given-names></name></person-group>
<article-title>Eosinophilic esophagitis</article-title>. <source><italic>Am J Roentgenol</italic></source>
<year>1981</year>; <volume>136</volume>:<fpage>1001</fpage>&#x2013;<lpage>1003</lpage>.<pub-id pub-id-type="pmid">6784497</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attwood</surname><given-names>SE</given-names></name><name><surname>Smyrk</surname><given-names>TC</given-names></name><name><surname>Demeester</surname><given-names>TR</given-names></name><etal/></person-group>
<article-title>Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome</article-title>. <source><italic>Dig Dis Sci</italic></source>
<year>1993</year>; <volume>38</volume>:<fpage>109</fpage>&#x2013;<lpage>116</lpage>.<pub-id pub-id-type="pmid">8420741</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syed</surname><given-names>AA</given-names></name><name><surname>Andrews</surname><given-names>CN</given-names></name><name><surname>Shaffer</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population-based study</article-title>. <source><italic>Aliment Pharmacol Ther</italic></source>
<year>2012</year>; <volume>36</volume>:<fpage>950</fpage>&#x2013;<lpage>958</lpage>.<pub-id pub-id-type="pmid">22994460</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevoff</surname><given-names>C</given-names></name><name><surname>Rao</surname><given-names>S</given-names></name><name><surname>Parsons</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>EUS and histopathologic correlates in eosinophilic esophagitis</article-title>. <source><italic>Gastrointest Endosc</italic></source>
<year>2001</year>; <volume>54</volume>:<fpage>373</fpage>&#x2013;<lpage>377</lpage>.<pub-id pub-id-type="pmid">11522985</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veerappan</surname><given-names>GR</given-names></name><name><surname>Perry</surname><given-names>JL</given-names></name><name><surname>Duncan</surname><given-names>TJ</given-names></name><etal/></person-group>
<article-title>Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study</article-title>. <source><italic>Clin Gastroenterol Hepatol</italic></source>
<year>2009</year>; <volume>7</volume>:<fpage>420</fpage>&#x2013;<lpage>426</lpage>.<pub-id pub-id-type="pmid">19162236</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Rhijn</surname><given-names>BD</given-names></name><name><surname>Verheij</surname><given-names>J</given-names></name><name><surname>Smout</surname><given-names>AJ</given-names></name><etal/></person-group>
<article-title>Rapidly increasing incidence of eosinophilic esophagitis in a large cohort</article-title>. <source><italic>Neurogastroenterol Motil</italic></source>
<year>2013</year>; <volume>25</volume>:<fpage>47</fpage>&#x2013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">22963642</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arias</surname><given-names>&#xC1;</given-names></name><name><surname>P&#xE9;rez-Mart&#xED;nez</surname><given-names>I</given-names></name><name><surname>Ten&#xED;as</surname><given-names>JM</given-names></name><etal/></person-group>
<article-title>Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies</article-title>. <source><italic>Aliment Pharmacol Ther</italic></source>
<year>2016</year>; <volume>43</volume>:<fpage>3</fpage>&#x2013;<lpage>15</lpage>.</mixed-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapel</surname><given-names>RC</given-names></name><name><surname>Miller</surname><given-names>JK</given-names></name><name><surname>Torres</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups</article-title>. <source><italic>Gastroenterology</italic></source>
<year>2008</year>; <volume>134</volume>:<fpage>1316</fpage>&#x2013;<lpage>1321</lpage>.<pub-id pub-id-type="pmid">18471509</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maradey-Romero</surname><given-names>C</given-names></name><name><surname>Prakash</surname><given-names>R</given-names></name><name><surname>Lewis</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>The 2011-2014 prevalence of oesohagitis in the elderly amongst 10 million patients in the United States</article-title>. <source><italic>Aliment Pharmacol Ther</italic></source>
<year>2015</year>; <volume>41</volume>:<fpage>1016</fpage>&#x2013;<lpage>1022</lpage>.<pub-id pub-id-type="pmid">25809664</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie</surname><given-names>SH</given-names></name><name><surname>Go</surname><given-names>M</given-names></name><name><surname>Chadwick</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Eosinophilic oesophagitis in patients presenting with dysphagia&#x2014;a prospective analysis</article-title>. <source><italic>Aliment Pharmacol Ther</italic></source>
<year>2008</year>; <volume>28</volume>:<fpage>1140</fpage>&#x2013;<lpage>1146</lpage>.<pub-id pub-id-type="pmid">18624788</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dellon</surname><given-names>ES</given-names></name><name><surname>Gonsalves</surname><given-names>N</given-names></name><name><surname>Hirano</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE)</article-title>. <source><italic>Am J Gastroenterol</italic></source>
<year>2013</year>; <volume>108</volume>:<fpage>679</fpage>&#x2013;<lpage>692</lpage>.<pub-id pub-id-type="pmid">23567357</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy-Ghanta</surname><given-names>S</given-names></name><name><surname>Larosa</surname><given-names>DF</given-names></name><name><surname>Katzka</surname><given-names>DA</given-names></name></person-group>
<article-title>Atopic characteristics of adult patients with eosinophilic esophagitis</article-title>. <source><italic>Clin Gastroenterol Hepatol</italic></source>
<year>2008</year>; <volume>6</volume>:<fpage>531</fpage>&#x2013;<lpage>535</lpage>.<pub-id pub-id-type="pmid">18304887</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dellon</surname><given-names>ES</given-names></name><name><surname>Jensen</surname><given-names>ET</given-names></name><name><surname>Martin</surname><given-names>CF</given-names></name><etal/></person-group>
<article-title>The prevalence of eosinophilic esophagitis in the United States</article-title>. <source><italic>Clin Gastroenterol Hepatol</italic></source>
<year>2014</year>; <volume>12</volume>:<fpage>589</fpage>&#x2013;<lpage>596</lpage>.<pub-id pub-id-type="pmid">24035773</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dellon</surname><given-names>ES</given-names></name><name><surname>Erichsen</surname><given-names>R</given-names></name><name><surname>Baron</surname><given-names>JA</given-names></name><etal/></person-group>
<article-title>The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark</article-title>. <source><italic>Aliment Pharmacol Ther</italic></source>
<year>2015</year>; <volume>41</volume>:<fpage>662</fpage>&#x2013;<lpage>670</lpage>.<pub-id pub-id-type="pmid">25684441</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sleiman</surname><given-names>PM</given-names></name><name><surname>March</surname><given-names>M</given-names></name><name><surname>Hakonarson</surname><given-names>H</given-names></name></person-group>
<article-title>The genetic basis of eosinophilic esophagitis</article-title>. <source><italic>Best Pract Res Clin Gastroenterol</italic></source>
<year>2015</year>; <volume>29</volume>:<fpage>701</fpage>&#x2013;<lpage>707</lpage>.<pub-id pub-id-type="pmid">26552769</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kottyan</surname><given-names>LC</given-names></name><name><surname>Davis</surname><given-names>BP</given-names></name><name><surname>Sherrill</surname><given-names>JD</given-names></name><etal/></person-group>
<article-title>Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease</article-title>. <source><italic>Nat Genet</italic></source>
<year>2014</year>; <volume>46</volume>:<fpage>895</fpage>&#x2013;<lpage>900</lpage>.<pub-id pub-id-type="pmid">25017104</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sleiman</surname><given-names>PM</given-names></name><name><surname>Wang</surname><given-names>ML</given-names></name><name><surname>Cianferoni</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>GWAS identifies four novel eosinophilic esophagitis loci</article-title>. <source><italic>Nat Commun</italic></source>
<year>2014</year>; <volume>5</volume>:<fpage>5593</fpage>.<pub-id pub-id-type="pmid">25407941</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>J</given-names></name><name><surname>Beukema</surname><given-names>KR</given-names></name><name><surname>Shen</surname><given-names>AH</given-names></name></person-group>
<article-title>Allergic mechanisms of Eosinophilic oesophagitis</article-title>. <source><italic>Best Pract Res Clin Gastroenterol</italic></source>
<year>2015</year>; <volume>29</volume>:<fpage>709</fpage>&#x2013;<lpage>720</lpage>.<pub-id pub-id-type="pmid">26552770</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philpott</surname><given-names>H</given-names></name><name><surname>Nandurkar</surname><given-names>S</given-names></name><name><surname>Thien</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Eosinophilic esophagitis: a clinicopathological review</article-title>. <source><italic>Pharmacol Ther</italic></source>
<year>2015</year>; <volume>146</volume>:<fpage>12</fpage>&#x2013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">25200122</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoepfer</surname><given-names>A</given-names></name></person-group>
<article-title>Diagnostic approach to eosinophilic oesophagitis: pearls and pitfalls</article-title>. <source><italic>Best Pract Res Clin Gastroenterol</italic></source>
<year>2015</year>; <volume>29</volume>:<fpage>783</fpage>&#x2013;<lpage>792</lpage>.<pub-id pub-id-type="pmid">26552777</pub-id></mixed-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>MH</given-names></name></person-group>
<article-title>Histopathologic features of eosinophilic esophagitis and eosinophilic gastrointestinal diseases</article-title>. <source><italic>Gastroenterol Clin North Am</italic></source>
<year>2014</year>; <volume>43</volume>:<fpage>257</fpage>&#x2013;<lpage>268</lpage>.<pub-id pub-id-type="pmid">24813514</pub-id></mixed-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngo</surname><given-names>P</given-names></name><name><surname>Furuta</surname><given-names>GT</given-names></name><name><surname>Antonioli</surname><given-names>DA</given-names></name><etal/></person-group>
<article-title>Eosinophils in the esophagus-peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia</article-title>. <source><italic>Am J Gastroenterol</italic></source>
<year>2006</year>; <volume>101</volume>:<fpage>1666</fpage>&#x2013;<lpage>1670</lpage>.<pub-id pub-id-type="pmid">16863575</pub-id></mixed-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina-Infante</surname><given-names>J</given-names></name><name><surname>Ferrando-Lamana</surname><given-names>L</given-names></name><name><surname>Ripoll</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults</article-title>. <source><italic>Clin Gastroenterol Hepatol</italic></source>
<year>2011</year>; <volume>9</volume>:<fpage>110</fpage>&#x2013;<lpage>117</lpage>.<pub-id pub-id-type="pmid">20920599</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina-Infante</surname><given-names>J</given-names></name><name><surname>Bredenoord</surname><given-names>AJ</given-names></name><name><surname>Cheng</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis</article-title>. <source><italic>Gut</italic></source>
<year>2016</year>; <volume>65</volume>:<fpage>524</fpage>&#x2013;<lpage>531</lpage>.<pub-id pub-id-type="pmid">26685124</pub-id></mixed-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dellon</surname><given-names>ES</given-names></name></person-group>
<article-title>Do you see what I see? Towards standardized reporting of endoscopic findings in eosinophilic esophagitis</article-title>. <source><italic>Endoscopy</italic></source>
<year>2014</year>; <volume>46</volume>:<fpage>1043</fpage>&#x2013;<lpage>1045</lpage>.<pub-id pub-id-type="pmid">25429629</pub-id></mixed-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirano</surname><given-names>I</given-names></name><name><surname>Moy</surname><given-names>N</given-names></name><name><surname>Heckman</surname><given-names>MG</given-names></name><etal/></person-group>
<article-title>Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system</article-title>. <source><italic>Gut</italic></source>
<year>2013</year>; <volume>62</volume>:<fpage>489</fpage>&#x2013;<lpage>495</lpage>.<pub-id pub-id-type="pmid">22619364</pub-id></mixed-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dellon</surname><given-names>ES</given-names></name><name><surname>Cotton</surname><given-names>CC</given-names></name><name><surname>Gebhart</surname><given-names>JH</given-names></name><etal/></person-group>
<article-title>Accuracy of the eosinophilic esophagitis endoscopic reference score in diagnosis and determining response to treatment</article-title>. <source><italic>Clin Gastroenterol Hepatol</italic></source>
<year>2016</year>; <volume>14</volume>:<fpage>31</fpage>&#x2013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">26404868</pub-id></mixed-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straumann</surname><given-names>A</given-names></name><name><surname>Conus</surname><given-names>S</given-names></name><name><surname>Degen</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis</article-title>. <source><italic>Gastroenterology</italic></source>
<year>2010</year>; <volume>139</volume>:<fpage>1526</fpage>&#x2013;<lpage>1537</lpage>.<pub-id pub-id-type="pmid">20682320</pub-id></mixed-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>JA</given-names></name><name><surname>Jung</surname><given-names>KW</given-names></name><name><surname>Arora</surname><given-names>AS</given-names></name><etal/></person-group>
<article-title>Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis</article-title>. <source><italic>Clin Gastroenterol Hepatol</italic></source>
<year>2012</year>; <volume>10</volume>:<fpage>742</fpage>&#x2013;<lpage>749</lpage>.<pub-id pub-id-type="pmid">22475741</pub-id></mixed-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucendo</surname><given-names>AJ</given-names></name><name><surname>De Rezende</surname><given-names>LC</given-names></name><name><surname>Jimenez-Contreras</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis</article-title>. <source><italic>Dig Dis Sci</italic></source>
<year>2011</year>; <volume>56</volume>:<fpage>3551</fpage>&#x2013;<lpage>3558</lpage>.<pub-id pub-id-type="pmid">21674173</pub-id></mixed-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netzer</surname><given-names>P</given-names></name><name><surname>Gschossmann</surname><given-names>JM</given-names></name><name><surname>Straumann</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission</article-title>. <source><italic>Eur J Gastroenterol Hepatol</italic></source>
<year>2007</year>; <volume>19</volume>:<fpage>865</fpage>&#x2013;<lpage>869</lpage>.<pub-id pub-id-type="pmid">17873610</pub-id></mixed-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothenberg</surname><given-names>ME</given-names></name><name><surname>Wen</surname><given-names>T</given-names></name><name><surname>Greenberg</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Intravenous anti&#x2013;IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis</article-title>. <source><italic>J Allergy Clin Immunol</italic></source>
<year>2015</year>; <volume>135</volume>:<fpage>500</fpage>&#x2013;<lpage>507</lpage>.<pub-id pub-id-type="pmid">25226850</pub-id></mixed-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vashi</surname><given-names>R</given-names></name><name><surname>Hirano</surname><given-names>I</given-names></name></person-group>
<article-title>Diet therapy for eosinophilic esophagitis: when, why and how</article-title>. <source><italic>Curr Opin Gastroenterol</italic></source>
<year>2013</year>; <volume>29</volume>:<fpage>407</fpage>&#x2013;<lpage>415</lpage>.<pub-id pub-id-type="pmid">23689524</pub-id></mixed-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doerfler</surname><given-names>B</given-names></name><name><surname>Bryce</surname><given-names>P</given-names></name><name><surname>Hirano</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Practical approach to implementing dietary therapy in adults with eosinophilic esophagitis: the Chicago experience</article-title>. <source><italic>Dis Esophagus</italic></source>
<year>2014</year>; <volume>28</volume>:<fpage>42</fpage>&#x2013;<lpage>58</lpage>.<pub-id pub-id-type="pmid">24602224</pub-id></mixed-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagalwalla</surname><given-names>AF</given-names></name><name><surname>Sentongo</surname><given-names>TA</given-names></name><name><surname>Ritz</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis</article-title>. <source><italic>Clin Gastroenterol Hepatol</italic></source>
<year>2006</year>; <volume>4</volume>:<fpage>1097</fpage>&#x2013;<lpage>1102</lpage>.<pub-id pub-id-type="pmid">16860614</pub-id></mixed-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonsalves</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>GY</given-names></name><name><surname>Doerfler</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors</article-title>. <source><italic>Gastroenterology</italic></source>
<year>2012</year>; <volume>142</volume>:<fpage>1451</fpage>&#x2013;<lpage>1459</lpage>.<pub-id pub-id-type="pmid">22391333</pub-id></mixed-citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aceves</surname><given-names>SS</given-names></name></person-group>
<article-title>Food allergy testing in eosinophilic esophagitis: what the gastroenterologist needs to know</article-title>. <source><italic>Clin Gastroenterol Hepatol</italic></source>
<year>2014</year>; <volume>12</volume>:<fpage>1216</fpage>&#x2013;<lpage>1223</lpage>.<pub-id pub-id-type="pmid">24035776</pub-id></mixed-citation>
      </ref>
      <ref id="R40">
        <label>40</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>M</given-names></name><name><surname>Mutlu</surname><given-names>EA</given-names></name><name><surname>Jakate</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Endoscopy in eosinophilic esophagitis: &#x201C;feline&#x201D; esophagus and perforation risk</article-title>. <source><italic>Clin Gastroenterol Hepatol</italic></source>
<year>2003</year>; <volume>1</volume>:<fpage>433</fpage>&#x2013;<lpage>437</lpage>.<pub-id pub-id-type="pmid">15017642</pub-id></mixed-citation>
      </ref>
      <ref id="R41">
        <label>41</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>MS</given-names></name><name><surname>Kaufman</surname><given-names>AB</given-names></name><name><surname>Palazzo</surname><given-names>JP</given-names></name><etal/></person-group>
<article-title>An audit of endoscopic complications in adult eosinophilic esophagitis</article-title>. <source><italic>Clin Gastroenterol Hepatol</italic></source>
<year>2007</year>; <volume>5</volume>:<fpage>1149</fpage>&#x2013;<lpage>1153</lpage>.<pub-id pub-id-type="pmid">17683993</pub-id></mixed-citation>
      </ref>
      <ref id="R42">
        <label>42</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saligram</surname><given-names>S</given-names></name><name><surname>McGarth</surname><given-names>K</given-names></name></person-group>
<article-title>The safety of a strict wire-guided dilation protocol for eosinophilic esophagitis</article-title>. <source><italic>Eur J Gastroenterol Hepatol</italic></source>
<year>2014</year>; <volume>26</volume>:<fpage>699</fpage>&#x2013;<lpage>703</lpage>.<pub-id pub-id-type="pmid">24901815</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
